COVID-19 Vaccine Tracker and Landscape (WHO, accessed 4 August 2021); https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
Kisby, T., Yilmazer, A. & Kostarelos, K. Reasons for success and lessons learnt from nanoscale vaccines against COVID-19. Nat. 나노 테크 놀. 16, 843-850 (2021).
Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. 거기. 핵산 15, 1-11 (2019).
커미르나티 Assessment Report EMA/707383/2020 (EMA, 2021); https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf
COVID-19 Vaccine Moderna Assessment Report EMA/15689/2021 (EMA, 2021); https://www.ema.europa.eu/en/documents/assessment-report/spikevax-previously-covid-19-vaccine-moderna-epar-public-assessment-report_en.pdf
Pfizer-BioNTech COVID-19 FDA Briefing Document (FDA, 2020); https://www.fda.gov/media/144245/download
Mahase, E. Covid-19: UK government asks regulator to assess Oxford vaccine as questions are raised over interim data. Brit. Med. 제이. 371, m4670 (2020).
Knoll, M. D. & Wonodi, C. Oxford–AstraZeneca COVID-19 vaccine efficacy. 랜싯 397, 72-74 (2021).
Rappuoli, R. & De Gregorio, E. Editorial overview: vaccines: novel technologies for vaccine development. 커. 의견. 면역. 41, v–vii (2016).
Calzolai, L., Gioria, S. & Magrì, D. Nanoparticle-Based Vaccines in Clinical Trial/Use for COVID-19 and Licensed for Other Pathogens (유럽위원회, 2021); https://data.jrc.ec.europa.eu/dataset/1575f3b3-f8e6-4f6c-a296-77e8d1be4ee1#citation
Lindsay, K.E.et al. PET-CT 및 근적외선 영상을 통해 인간이 아닌 영장류에서 mRNA 백신 전달의 초기 이벤트 시각화. Nat. 생체. 영어 3, 371-380 (2019).
Hall, J. B., Dobrovolskaia, M. A., Patri, A. K. & McNeil, S. E. Characterization of nanoparticles for therapeutics. 나노 의학 2, 789-803 (2007).
Drug Products, Including Biological Products, that Contain Nanomaterials—Guidance for Industry (FDA, 2017); https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-products-including-biological-products-contain-nanomaterials-guidance-industry
Faria, M.et al. 바이오 나노 실험 문헌에서보고하는 최소한의 정보. Nat. 나노 테크 놀. https://doi.org/10.1038/s41565-018-0246-4 (2018).
Leong, HS et al. 나노 의학의 투명성과 재현성 문제. Nat. 나노 테크 놀. 14, 629-635 (2019).
Hassett, KJet al. mRNA 백신 면역원성에 대한 지질 나노입자 크기의 영향. J. 통제. 해제 335, 237-246 (2021).
Caputo, F. et al. Measuring particle size distribution and mass concentration of nanoplastics and microplastics: addressing some analytical challenges in the sub-micron size range. J. 콜로이드 인터페이스 과학. https://doi.org/10.1016/j.jcis.2020.12.039 (2021).
Parot, J., Caputo, F., Mehn, D., Hackley, V. A. & Calzolai, L. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation. J. 통제. 해제 320, 495-510 (2020).
Mildner, R. et al. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery. 유로 제이팜. 바이오팜. 163, 252-265 (2021).
Mehn, D., Capomaccio, R., Gioria, S., Gilliland, D. & Calzolai, L. Analytical ultracentrifugation for measuring drug distribution of doxorubicin loaded liposomes in human serum. J. Nanopart. 입술. 22, 1-7 (2020).
Tran, J. C. et al. Mapping intact protein isoforms in discovery mode using top-down proteomic. 자연 480, 254-258 (2011).
Tanguay, R. L. & Gallie, D. R. Translational efficiency is regulated by the length of the 3′ untranslated region. Mol. 세포. Biol. 16, 146-156 (1996).
Beverly, M., Dell, A., Parmar, P. & Houghton, L. Label-free analysis of mRNA capping efficiency using RNase H probes and LC–MS. 항문. Bioanal. Chem. 408, 5021-5030 (2016).
Varenne, F. et al. Standardization and validation of a protocol of zeta potential measurements by electrophoretic light scattering for nanomaterial characterization. Colloids Surf. https://www.sciencedirect.com/science/article/abs/pii/S0927775715301862 (2015).
Reijenga, J., Van Hoof, A., Van Loon, A. & Teunissen, B. Development of methods for the determination of pKa values. Anal. Chem. Insights https://journals.sagepub.com/doi/full/10.4137/ACI.S12304 (2013).
Capua, I. & Giaquinto, C. The unsung virtue of thermostability. 랜싯 397, 1346 (2021).
Guerrini, G. et al. Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines. 백신 9, 544 (2021).
Durowoju, I. B., Bhandal, K. S., Hu, J., Carpick, B. & Kirkitadze, M. Differential scanning calorimetry—a method for assessing the thermal stability and conformation of protein antigen. J. 비스. 특급. https://www.jove.com/t/55262/differential-scanning-calorimetry-method-for-assessing-thermal (2017).
Crist, R. M. et al. Common pitfalls in nanotechnology: lessons learned from NCI’s Nanotechnology Characterization Laboratory. 통합 바이올. 5, 66-73 (2013).
Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118 (1994).
Hubo, M. et al. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. 앞. 면역. 4, 82 (2013).
Cupedo, T., Stroock, A. D. & Coles, M. C. Application of tissue engineering to the immune system: development of artificial lymph nodes. 앞. 면역. 3, 3389 (2012).
Wagar, L. E. et al. Modeling human adaptive immune responses with tonsil organoids. Nat. Med. 27, 125-135 (2021).
Haile, L. A. et al. Cell based assay identifies TLR2 and TLR4 stimulating impurities in interferon beta. Sci. 대표. 7, 10490 (2017).
Della Camera, G. et al. A step-by-step approach to improve clinical translation of liposome-based nanomaterials, a focus on innate immune and inflammatory responses. 국제 J.Mol. 과학 22, 820 (2021).
Szebeni, J. & Moghimi, S. M. Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions. J. 리포솜 Res. 19, 85-90 (2009).
Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M. & Nazy, I. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. 자연 596, 565-569 (2021).
Greinacher, A. et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. 엔글. J. Med. 384, 2092-2101 (2021).
Non-Clinical Evaluation of Vaccines (WHO); https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/non-clinical-evaluation-of-vaccines
Manual of Laboratory Methods for Testing of Vaccines used in the WHO Expanded Programme on Immunization (WHO, 1997); https://apps.who.int/iris/handle/10665/63576
실험실 생물안전 매뉴얼 4판(WHO, 2020); https://www.who.int/publications/i/item/9789240011311
Pardi, N. et al. 다양한 경로를 통해 지질 나노입자로 마우스에 전달된 뉴클레오시드 변형 mRNA의 발현 동역학. J. 통제. 해제 217, 345-351 (2015).
Tan, C. W. et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat. 바이오 테크 놀. 38, 1073-1078 (2020).
Fiorino, F., Pettini, E., Pozzi, G., Medaglini, D. & Ciabattini, A. Prime-boost strategies in mucosal immunization affect local IgA production and the type of the response. 앞. 이 뮤놀 4, 128 (2003).
Medaglini, D. et al. In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant 연쇄상구균 고르도니. 감염. Immun. 74, 2760-2766 (2006).
Ciabattini, A. Evidence of SARS-CoV-2-specific memory B cells six months after vaccination with the BNT162b2 mRNA vaccine. 앞. 이 뮤놀 12, 3389 (2021).
Pastore, G. et al. Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies. 앞. 면역. 10, 2304 (2019).
Lucchesi, S. et al. Computational analysis of multiparametric flow cytometric data to dissect B cell subsets in vaccine studies. 세포 계측법 A 97, 259-267 (2020).
Gilbert, P. B. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. 과학 375, 43-50 (2022).
DiPiazza, A. T. et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. 면제 54, 1869-1882 (2021).
Jiang, R.-D. et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. 세포 182, 50-58 (2020).
Urano, E. et al. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions. Proc. Natl. Acad. Sci. 미국 118, e210484711 (2021).
Ciabattini, A. et al. Vaccination in the elderly: the challenge of immune changes with aging. 세민 면역. 40, 83-94 (2018).
Ciabattini, A. et al. Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population. 세민. 면역병리학. 42, 619-634 (2020).
Jansen, K. U. & Anderson, A. S. The role of vaccines in fighting antimicrobial resistance (AMR). 흠. 백신. 면역. 14, 2142-2149 (2018).
